Metastatic Hormone Receptor-Positive Breast Carcinoma
8 clinical trials · Condition
◉ Watch Metastatic Hormone Receptor-Positive Breast Carcinoma
| Record | Firm | Date |
|---|---|---|
| Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer (NCT05098210) | Fred Hutchinson Cancer Center | 2022-06-09 |
| Testing the Addition of Copanlisib to Usual Treatment (Fulvestrant and Abemaciclib) in Metastatic Breast Cancer (NCT03939897) | National Cancer Institute (NCI) | 2020-06-17 |
Track Metastatic Hormone Receptor-Positive Breast Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.